IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 136 filers reported holding IMMUNITYBIO INC in Q2 2022. The put-call ratio across all filers is 1.87 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,161,995 | -39.2% | 687,571 | 0.0% | 0.16% | -37.0% |
| Q2 2023 | $1,911,447 | +52.7% | 687,571 | 0.0% | 0.26% | +44.4% |
| Q1 2023 | $1,251,379 | -64.1% | 687,571 | 0.0% | 0.18% | -64.0% |
| Q4 2022 | $3,485,985 | +2.0% | 687,571 | 0.0% | 0.50% | -7.8% |
| Q3 2022 | $3,417,000 | +33.6% | 687,571 | 0.0% | 0.54% | +46.3% |
| Q2 2022 | $2,558,000 | -33.7% | 687,571 | 0.0% | 0.37% | -26.6% |
| Q1 2022 | $3,857,000 | -7.7% | 687,571 | 0.0% | 0.50% | -10.9% |
| Q4 2021 | $4,180,000 | -37.6% | 687,571 | 0.0% | 0.56% | -43.4% |
| Q3 2021 | $6,697,000 | -31.8% | 687,571 | 0.0% | 0.99% | -33.8% |
| Q2 2021 | $9,819,000 | – | 687,571 | – | 1.50% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Winning Points Advisors, LLC | 236,956 | $879,000 | 0.97% |
| HARBOURVEST PARTNERS LLC | 335,709 | $1,249,000 | 0.41% |
| ALLEN HOLDING INC /NY | 687,571 | $2,558,000 | 0.37% |
| MERIDIAN INVESTMENT COUNSEL INC. | 96,433 | $359,000 | 0.15% |
| SHEETS SMITH WEALTH MANAGEMENT | 207,926 | $773,000 | 0.13% |
| Corton Capital Inc. | 29,032 | $108,000 | 0.10% |
| Clearwater Capital Advisors, LLC | 185,311 | $689,000 | 0.09% |
| Delphia (USA) Inc. | 31,709 | $118,000 | 0.08% |
| Virtus ETF Advisers LLC | 34,799 | $129,000 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 84,884 | $316,000 | 0.05% |